Fonte: ChemistrySelect. Unidades: FCFRP, FFCLRP
Assuntos: ANTINEOPLÁSICOS, ANTI-HISTAMÍNICOS, RUTÊNIO
ABNT
CACITA, Natacha et al. Interactions with HSA, anticancer and antiallergic activity of binuclear μ‐oxo bridged ruthenium acetate compounds. ChemistrySelect, v. 8, n. 13, p. 1-11, 2023Tradução . . Disponível em: https://doi.org/10.1002/slct.202300285. Acesso em: 29 ago. 2024.APA
Cacita, N., Silva, A. B., Santos, N. A. P. dos, Ramos, L. C. B., Del Lama, M. P. F. de M., Naal, R. M. Z. G., & Nikolaou, S. (2023). Interactions with HSA, anticancer and antiallergic activity of binuclear μ‐oxo bridged ruthenium acetate compounds. ChemistrySelect, 8( 13), 1-11. doi:10.1002/slct.202300285NLM
Cacita N, Silva AB, Santos NAP dos, Ramos LCB, Del Lama MPF de M, Naal RMZG, Nikolaou S. Interactions with HSA, anticancer and antiallergic activity of binuclear μ‐oxo bridged ruthenium acetate compounds [Internet]. ChemistrySelect. 2023 ; 8( 13): 1-11.[citado 2024 ago. 29 ] Available from: https://doi.org/10.1002/slct.202300285Vancouver
Cacita N, Silva AB, Santos NAP dos, Ramos LCB, Del Lama MPF de M, Naal RMZG, Nikolaou S. Interactions with HSA, anticancer and antiallergic activity of binuclear μ‐oxo bridged ruthenium acetate compounds [Internet]. ChemistrySelect. 2023 ; 8( 13): 1-11.[citado 2024 ago. 29 ] Available from: https://doi.org/10.1002/slct.202300285